US2022127237A1PendingUtilityA1

Fluorescent pyrazine derivatives and methods of using the same in assessing renal function

Assignee: MEDIBEACON INCPriority: Dec 23, 2004Filed: Jan 3, 2022Published: Apr 28, 2022
Est. expiryDec 23, 2024(expired)· nominal 20-yr term from priority
A61K 49/0004A61K 49/0021C07D 241/28A61K 49/0052A61K 31/4965C07D 241/26C07D 241/20C07D 487/14B01J 2219/1206
76
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to pyrazine derivatives such as those represented by Formulas I and II. X1 to X4 formulas I and II may be characterized as electron withdrawing groups, white Y1 to Y4 of Formulas I and II may be characterized as electron donating groups. Pyrazine derivatives of the present invention may be utilized in assessing organ (e.g., kidney) function. In a particular example, an effective amount of a pyrazine derivative that is capable of being renally cleared may be administered into a patient's body. The pyrazine derivative may capable of one or both absorbing and emanating spectral energy of at least about 400 nm (e.g., visible and/or infrared light). At least some of the derivative that is in the body may be exposed to spectral energy and, in turn, spectral energy may emanate from the derivative. This emanating spectral energy may be detected and utilized to determine renal function of the patient.

Claims

exact text as granted — not AI-modified
1 - 44 . (canceled) 
     
     
         45 . A method for preparing 2,5-diaminopyrazine-3,6-dicarboxylic acid, the method comprising irradiating with microwaves a hydrolysis mixture comprising 2,4,6,8-tetrahydroxypyrimido(4,5-g)pteridine or a salt thereof. 
     
     
         46 . The method of  claim 45 , wherein the irradiating heats the hydrolysis mixture as the 2,4,6,8-tetrahydroxypyrimido(4,5-g)pteridine or a salt thereof is hydrolyzed. 
     
     
         47 . The method of  claim 45 , wherein the microwaves have a frequency in a range of from about 300 MHz to about 30 GHz. 
     
     
         48 . The method of  claim 45 , wherein the hydrolysis mixture is an aqueous hydrolysis mixture. 
     
     
         49 . The method of  claim 45 , wherein the irradiating heats the hydrolysis mixture to a temperature within a range of from about 120° C. to about 180° C. 
     
     
         50 . The method of  claim 45 , wherein the hydrolysis mixture is irradiated for a period of from about 30 minutes to about 90 minutes. 
     
     
         51 . The method of  claim 45 , wherein the hydrolysis mixture is irradiated in a sealed microwave reactor. 
     
     
         52 . The method of  claim 45 , wherein the irradiating heats the hydrolysis mixture to a temperature within a range of from about 120° C. to about 140° C. for a period of from about 45 minutes to about 75 minutes. 
     
     
         53 . The method of  claim 45 , wherein the hydrolysis mixture further comprises a base. 
     
     
         54 . The method of  claim 45 , wherein the hydrolysis mixture further comprises a base selected from the group consisting of alkali metal hydroxides, potassium hydroxide, and sodium hydroxide. 
     
     
         55 . 2,5-diaminopyrazine-3,6-dicarboxylic acid produced according to the method of  claim 45 . 
     
     
         56 . A method for preparing 2,5-diaminopyrazine-3,6-dicarboxylate, the method comprising
 preparing the 2,5-diaminopyrazine-3,6-dicarboxylic acid according to  claim 45 ; and   acidifying the irradiated mixture.   
     
     
         57 . The method of  claim 56 , wherein the acidifying comprises acidifying the irradiated mixture with a mineral acid selected from the group consisting of hydrochloric acid, sulfuric acid, and phosphoric acid. 
     
     
         58 . 2,5-diaminopyrazine-3,6-dicarboxylate produced according to the method of  claim 56 .

Join the waitlist — get patent alerts

Track US2022127237A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.